These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 10944127

  • 1. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A, Margaria E, Chiusa L.
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [Abstract] [Full Text] [Related]

  • 2. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
    Pich A, Margaria E, Chiusa L, Bortolin P, Palestro G.
    Oncol Rep; 2003 Aug; 10(5):1329-35. PubMed ID: 12883702
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
    Pich A, Margaria E, Chiusa L, Candelaresi G, Dal Canton O.
    Br J Cancer; 1999 Feb; 79(5-6):959-64. PubMed ID: 10070897
    [Abstract] [Full Text] [Related]

  • 4. Oncogenes in male breast cancer.
    Idelevich E, Mozes M, Ben-Baruch N, Huszar M, Kruglikova A, Katsnelson R, Shani A.
    Am J Clin Oncol; 2003 Jun; 26(3):259-61. PubMed ID: 12796596
    [Abstract] [Full Text] [Related]

  • 5. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 7. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, Doctor SS, Shah NG, Balar DB.
    Dis Colon Rectum; 1997 Jul 12; 40(7):785-90. PubMed ID: 9221853
    [Abstract] [Full Text] [Related]

  • 8. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC, Garijo MF, Fernández F, Val-Bernal JF.
    Histol Histopathol; 2001 Apr 12; 16(2):399-406. PubMed ID: 11332695
    [Abstract] [Full Text] [Related]

  • 9. Male breast cancer: Looking for better prognostic subgroups.
    Abreu MH, Afonso N, Abreu PH, Menezes F, Lopes P, Henrique R, Pereira D, Lopes C.
    Breast; 2016 Apr 12; 26():18-24. PubMed ID: 27017238
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M, Athanassiadou AM, Patsouris E, Tsipis A, Dimopoulos S, Kyriakidou V, Chelidonis G, Athanassiadou P.
    Pathol Res Pract; 2011 Jun 15; 207(6):377-82. PubMed ID: 21621926
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 12. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J, Visakorpi T, Holli K, Kallioniemi OP.
    J Natl Cancer Inst; 1992 Jul 15; 84(14):1109-14. PubMed ID: 1352359
    [Abstract] [Full Text] [Related]

  • 13. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
    Borre M, Stausbol-Gron B, Overgaard J.
    J Urol; 2000 Sep 15; 164(3 Pt 1):716-21. PubMed ID: 10953132
    [Abstract] [Full Text] [Related]

  • 14. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.
    Am J Clin Pathol; 1992 Oct 15; 98(4):408-18. PubMed ID: 1357956
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 15; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 16. Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas.
    Luna-Moré S, de los Santos F, Bretón JJ, Cañadas MA.
    Pathol Res Pract; 1996 Jan 15; 192(1):27-32. PubMed ID: 8685038
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.
    Erdem O, Dursun A, Coşkun U, Günel N.
    Tumori; 2005 Jan 15; 91(1):46-52. PubMed ID: 15850004
    [Abstract] [Full Text] [Related]

  • 18. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P, Alm P, Olsson H, Heidebrecht HJ, Fernö M, Baldetorp B, Parwaresch R.
    Hum Pathol; 2001 Mar 15; 32(3):311-9. PubMed ID: 11274641
    [Abstract] [Full Text] [Related]

  • 19. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB, Papadimitriou JC, Drachenberg CB.
    Hum Pathol; 1998 Oct 15; 29(10):1150-9. PubMed ID: 9781657
    [Abstract] [Full Text] [Related]

  • 20. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.
    Hum Pathol; 2001 May 15; 32(5):487-93. PubMed ID: 11381366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.